Francisco
Marin Ortuño
Profesores Titulares de Universidad Vinculados H.V.Arrixaca
Hospital Universitario Reina Sofia
Córdoba, EspañaPublications in collaboration with researchers from Hospital Universitario Reina Sofia (49)
2024
-
Incidence and clinical impact of inappropriate periprocedural and perioperative management of antiplatelet therapy
Medicina Clinica, Vol. 163, Núm. 7, pp. 336-343
-
Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties?
Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 701-703
-
Therapeutic management of CNIC polypill at discharge from a first acute coronary syndrome in Spain: the PANDORA study
REC: CardioClinics
2023
-
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment
American Journal of Cardiology, Vol. 203, pp. 122-127
-
Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in “real world”: the REQXAA study
Revista Espanola de Cardiologia, Vol. 76, Núm. 9, pp. 729-738
2022
-
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry
Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465
-
Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP-AF Long-term General Registry
European Journal of Clinical Investigation, Vol. 52, Núm. 4
-
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry
Europace, Vol. 24, Núm. 2, pp. 202-210
-
Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry
Frontiers in Cardiovascular Medicine, Vol. 9
-
Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study
European Journal of Clinical Investigation
-
Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 1, pp. 4-11
2021
-
Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes
European Journal of Clinical Investigation, Vol. 51, Núm. 5
-
Impact of sex differences and network systems on the in-hospital mortality of patients with ST-segment elevation acute myocardial infarction
Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 927-934
-
In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide spanish database
Cardiology Journal, Vol. 28, Núm. 4, pp. 589-597
-
Incidence and outcomes of hospital treated acute myocarditis from 2003 to 2015 in Spain
European Journal of Clinical Investigation, Vol. 51, Núm. 4
-
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry
European Journal of Clinical Investigation, Vol. 51, Núm. 4
-
Relationship between multimorbidity and outcomes in atrial fibrillation
Experimental Gerontology, Vol. 153
-
Sex bias in admission to tertiary-care centres for acute myocardial infarction and cardiogenic shock
European Journal of Clinical Investigation, Vol. 51, Núm. 7
-
Temporal trends in hospitalization and in-hospital mortality rates due to heart failure by age and sex in Spain (2003-2018)
Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 994-996
-
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: Impact of inappropriate doses (the EMIR study)
Journal of Comparative Effectiveness Research, Vol. 10, Núm. 7, pp. 583-593